Report #2849343

Overview

Sex

Female

Age

Age unknown

State

WA

Recovered

Unknown

Vaccinated

Jul 10, 2025

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Patient was given ceftriaxone 500 mg with 1 mL diluent instead of Bicillin L-A 1,200,000 units/2 mL; Case reference number US-BN-2025-001551, initially downloaded from Vaccine Adverse Event Reporting System (VAERS) on 08-Sep-2025, is a spontaneous case received from other health care professional via Health Authority (VAERS ID: 2849343-1) and concerns a 23-year-old female patient. The patient's medical history was not provided. The patient's concomitant medications included Keppra (levetiracetam), lamotrigine 350 mg (brand name unknown), levetiracetam 500 mg (brand name unknown), Nayzilam 5 mg (midazolam), zonisamide 100 mg (brand name unknown), and Nexplanon (etonogestrel). On 10-Jul-2025, the patient received the Vimkunya, along with its constituent part, preffiled syringe (batch number: unknown) at an unknown dose, route of administration, or site of administration for an unknown indication. As reported, the patient was given ceftriaxone 500 mg with 1 mL diluent instead of Bicillin L-A 1,200,000 units/2 mL (explicitly coded as 'Product preparation error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vimkunya vaccine. No further information was provided.; Reporter's Comments: A 23-year-old female patient received the Jynneos vaccine for an unknown indication. As reported, the patient was given ceftriaxone 500 mg with 1 mL diluent instead of Bicillin L-A 1,200,000 units/2 mL, which is considered as product preparation error. It was unknown if the patient experienced any adverse event due to Jynneos vaccine. Product preparation error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product preparation error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 23-year-old female patient received the Jynneos vaccine for an unknown indication. As reported, the patient was given ceftriaxone 500 mg with 1 mL diluent instead of Bicillin L-A 1,200,000 units/2 mL, which is considered as product preparation error. It was unknown if the patient experienced any adverse event due to Jynneos vaccine. Product preparation error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product preparation error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.

Medical history

Comments: NONE

Other medications

KEPPRA [LEVETIRACETAM]; LAMOTRIGINE; LEVETIRACETAM; NAYZILAM; ZONISAMIDE; NEXPLANON